Clinical Trials
Artificial Intelligence – Giving Clinical Trial A Facelift
Across the past so many years, there have been pharmaceutical companies that have been integrating artificial intelligence steadily into many elements of clinical development. The...
Clinical Trials
New Data Shows Gazyva’s Superiority in Lupus Nephritis
The New England Journal of Medicine has published detailed findings from Roche’s Phase III REGENCY trial, which demonstrated the superiority of Gazyva®/Gazyvaro® (obinutuzumab) in combination...
Clinical Trials
EYLEA HD® Phase 3 Trial Yields Promising Results
Regeneron Pharmaceuticals, Inc. announced promising results from the Phase 3 QUASAR trial investigating EYLEA HD® (aflibercept) Injection 8 mg for treating macular edema in patients...
Clinical Trials
Pfizer’s BRAFTOVI Improves Survival in Phase 3 Trial
Pfizer has announced groundbreaking results from the Phase 3 BREAKWATER trial, showcasing the effectiveness of its BRAFTOVI® (encorafenib) combination regimen in the treatment of metastatic...
Clinical Trials
VerZom achieves first bioproduction of clinical grade stem cell-derived...
EVerZom, a biopharmaceutical company developing  exosome based biodrugs, announces that it has reached a key milestone in its development with the production of a first exosome GMP batch in a 10L bioreactor with unprecedented...
Clinical Trials
New Endometrial Cancer Therapy Phase-II Trial Shows Promise
The most recent trial of a new antibody drug that goes on to deliver potent chemotherapy that too directly to the cancer cells for patients...
Clinical Trials
Duality Looks Out For Hong Kong IPO To Finance...
Duality Biotherapeutics from China has gone ahead and filed paperwork as far as a Hong Kong IPO is concerned, thereby looking out for an undisclosed...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.